Medical Condition News

RSS

Aggressive medical management better than stenting for prevention of recurrent stroke

Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.

8 Sep 2011

New studies on breast cancer screening, treatment and survival

New studies on breast cancer screening, treatment, and survival were released today in advance of the 2011 Breast Cancer Symposium. The symposium is being held September 8-10, 2011, at the San Francisco Marriott Marquis in San Francisco.

8 Sep 2011

Enrollment complete in Concentric Medical's Stentriever trial for acute ischemic stroke

Concentric Medical, Inc., a global leader in acute ischemic stroke intervention, today announced completion of enrollment of the TREVO Study.

8 Sep 2011

Naturopathic medicine helps reduce doctors' use of prescription drugs

A new survey commissioned by the Canadian College of Naturopathic Medicine reveals that almost half of Ontarians treated by naturopathic doctors report naturopathic medicine has helped reduce their use of prescription drugs.

8 Sep 2011

Microvascular compression syndrome may cause Parkinson's

A potentially treatable blood vessel abnormality in the brain may be the cause of Parkinson's Disease in some patients, according to a study published today in the journal Neurology International by a team of leading physicians and neuroscientists at Pittsburgh's Allegheny General Hospital.

8 Sep 2011

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.

From Santen Pharmaceutical Co., Ltd. 8 Sep 2011

Dysregulated neuronal RNA transport may cause Fragile X-associated tremor/ataxia syndrome

SUNY Downstate scientist Ilham Muslimov, MD, PhD, along with senior author Henri Tiedge, PhD, professor of physiology and pharmacology and of neurology, published a study suggesting that cellular dysregulation associated with certain neurodegenerative disorders may result from molecular competition in neuronal RNA transport pathways.

8 Sep 2011

Researchers identify bouncer protein that plays a vital role in RA prevention

Researchers at Northwestern University Feinberg School of Medicine have discovered why the immune cells of people with rheumatoid arthritis become hyperactive and attack the joints and bones. The immune cells have lost their bouncer, the burly protein that keeps them in line the same way a bouncer in a nightclub controls rowdy patrons.

8 Sep 2011

'Chaperone' protein may play a critical role in pathogenesis of heart failure

Researchers at Mount Sinai School of Medicine have identified a new drug target that may treat and/or prevent heart failure. The team evaluated failing human and pig hearts and discovered that SUMO1, a so-called "chaperone" protein that regulates the activity of key transporter genes, was decreased in failing hearts.

8 Sep 2011

Aggressive medical treatment without stenting better for high-risk stroke patients

An article appearing in the Sept. 7 New England Journal of Medicine, reporting on National Institutes of Health research on brain stents, says aggressive medical treatment without stenting is better for high-risk stroke patients.

8 Sep 2011

Scientists discover backup circuits in cetuximab-resistant cancer cells

Scientists at Dana-Farber Cancer Institute and colleagues overseas have discovered a pair of backup circuits in cancer cells that enable the cells to dodge the effect of a widely used cancer drug.

8 Sep 2011

Intensive medical treatment more effective in preventing second stroke than stenting

People who received intensive medical treatment following a first stroke had fewer second episodes and were less likely to die than people who received brain stents in addition to medical treatment, according to a new report in the New England Journal of Medicine, to be published online Sept. 7.

8 Sep 2011

Capsules: Deficit hawk or dove? Enzi's autism stance

On Kaiser Health News' news blog, Phil Galewitz examines Sen. Mike Enzi's efforts to provide federal funds for autism research, even as the Wyoming Republican calls for major budget cuts.

8 Sep 2011

Hospitals: HHS inspector general counsel backs telemedicine plan for stroke care program

Hospital issues making headlines include a telemedicine plan, the unreliability of some children's hospital rankings and how long hospital wait times can be deadly.

8 Sep 2011

Researchers identify new drug target for heart failure

8 Sep 2011

Natural ruminant trans fats are not detrimental to health

Not all trans fats are created equal and it's time for nutritional labels to reflect that reality, says a University of Alberta nutrition expert.

8 Sep 2011

ATA announces five recipients of 2011 thyroid cancer research grants

The American Thyroid Association (ATA) announced the five recipients of its 2011 research grants, each of whom will receive up to $25,000 annually for up to two years. Three of the five recipients were awarded special ATA ThyCa grants for research projects that focus on thyroid cancer. These grants are funded by ThyCa: Thyroid Cancer Survivors, Inc.

8 Sep 2011

Pharnext puts together €2.5M to fund development of Pleodrug for Charcot-Marie-Tooth disease

Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).

8 Sep 2011

Apply lessons from the AIDS response to NCD control and prevention in developing countries

In anticipation of the September 2011 U.N. High-level Meeting on Non-Communicable Diseases (NCDs), low- and middle-income countries "should not only look at the lessons learned in the control of NCDs in developed countries, but also those from other areas of public health, especially AIDS, which can inform the design of an effective and sustainable response to NCDs in developing countries," Rebecca Dirks from FHI 360 and colleagues write in this PLoS Medicine Policy Forum editorial piece.

8 Sep 2011

Cam impingement may increase risk of hip OA in young men

Hip impingement may be a risk factor of osteoarthritis (OA) of the hip. A new study reveals that the presence of an underlying deformity, known as cam impingement, is associated with hip damage in young men without any arthritis symptoms and detected using magnetic resonance imaging.

8 Sep 2011

Medical Condition News

Aggressive medical management better than stenting for prevention of recurrent stroke

New studies on breast cancer screening, treatment and survival

Enrollment complete in Concentric Medical's Stentriever trial for acute ischemic stroke

Naturopathic medicine helps reduce doctors' use of prescription drugs

Microvascular compression syndrome may cause Parkinson's

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Dysregulated neuronal RNA transport may cause Fragile X-associated tremor/ataxia syndrome

Researchers identify bouncer protein that plays a vital role in RA prevention

'Chaperone' protein may play a critical role in pathogenesis of heart failure

Aggressive medical treatment without stenting better for high-risk stroke patients

Scientists discover backup circuits in cetuximab-resistant cancer cells

Intensive medical treatment more effective in preventing second stroke than stenting

Capsules: Deficit hawk or dove? Enzi's autism stance

Hospitals: HHS inspector general counsel backs telemedicine plan for stroke care program

Researchers identify new drug target for heart failure

Natural ruminant trans fats are not detrimental to health

ATA announces five recipients of 2011 thyroid cancer research grants

Pharnext puts together €2.5M to fund development of Pleodrug for Charcot-Marie-Tooth disease

Apply lessons from the AIDS response to NCD control and prevention in developing countries

Cam impingement may increase risk of hip OA in young men

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News